Erin Quirk - President, Head of R&D at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D
Issuer Symbol
TERN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Erin Quirk since 09 Mar 2025

Holdings reported by Erin Quirk for Terns Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 75,000 $283,500 $3.78 23 Jan 2024 Direct
Stock Option (Right to Buy) 150,000 23 Jan 2024 Direct Common Stock

Transactions reported by Erin Quirk for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.